SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
06-Mar-24 4:50 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 05-Mar-24 | Sale | 8,941 | $4.18 | $37,395.70 | (4%) 205.77K to 196.82K | |
06-Mar-24 4:50 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 04-Mar-24 | Sale | 8,147 | $4.41 | $35,916.90 | (4%) 213.91K to 205.77K | |
21-Feb-24 4:53 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 16-Feb-24 | Grant | 125,000 | -- | -- | 141% 88.91K to 213.91K | |
15-Jun-23 4:20 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 13-Jun-23 | Sale | 14,600 | $6.56 | $95,754.10 | (14%) 103.51K to 88.91K | |
06-Mar-23 6:26 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 03-Mar-23 | Sale | 8,301 | $6.25 | $51,887.10 | (7%) 111.81K to 103.51K | |
06-Mar-23 6:26 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 02-Mar-23 | Sale | 8,437 | $6.24 | $52,684.80 | (7%) 120.25K to 111.81K | |
21-Feb-23 6:11 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 16-Feb-23 | Grant | 32,700 | -- | -- | 37% 87.55K to 120.25K | |
16-Dec-22 4:38 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 15-Dec-22 | Sale | 8,000 | $7.01 | $56,069.60 | (8%) 95.55K to 87.55K | |
17-Aug-22 4:06 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 15-Aug-22 | Sale | 8,300 | $10.30 | $85,504.30 | (8%) 103.85K to 95.55K | |
02-Mar-22 9:29 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 02-Mar-22 | Sale | 12,060 | $11.09 | $133,779.00 | (10%) 115.91K to 103.85K | |
02-Mar-22 9:29 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 28-Feb-22 | Grant | 32,700 | -- | -- | 39% 83.21K to 115.91K | |
08-Mar-21 5:47 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 05-Mar-21 | Market Sale | 5,600 | $17.85 | $99,966.00 | (6%) 92.53K to 86.93K | (2%) |
03-Mar-21 6:43 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 02-Mar-21 | Market Sale | 7,674 | $18.54 | $142,307.00 | (8%) 100.2K to 92.53K | 3% |
03-Mar-21 6:43 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 01-Mar-21 | Market Sale | 11,856 | $18.60 | $220,543.00 | (11%) 112.06K to 100.2K | 4% |
26-Feb-21 5:19 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 24-Feb-21 | Grant | 32,700 | -- | -- | 41% 79.36K to 112.06K | |
17-Aug-20 4:42 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 14-Aug-20 | Market Sale | 3,684 | $11.81 | $43,526.10 | (4%) 83.04K to 79.36K | (12%) |
04-Mar-20 5:03 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 03-Mar-20 | Market Sale | 1,237 | $10.51 | $13,003.80 | (1%) 84.28K to 83.04K | (26%) |
04-Mar-20 5:03 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 02-Mar-20 | Market Sale | 3,148 | $10.30 | $32,435.70 | (4%) 87.42K to 84.28K | (29%) |
28-Feb-20 6:05 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 26-Feb-20 | Grant | 30,000 | -- | -- | 52% 57.42K to 87.42K | |
15-Aug-19 4:58 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 14-Aug-19 | Market Sale | 2,575 | $14.69 | $37,829.30 | (4%) 60.0K to 57.42K | 10% |
01-Mar-19 4:27 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 27-Feb-19 | Grant | 30,000 | -- | -- | 100% 30.0K to 60.0K | |
14-Aug-18 5:06 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 13-Aug-18 | Grant | 30,000 | -- | -- | 100% 0 to 30.0K |